AI assistant
Sending…
Instil Bio, Inc. — Director's Dealing 2024
Jan 11, 2024
33728_dirs_2024-01-10_1cf67a49-0ba7-4b3e-86f2-7d12307ec5e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2023-06-14
Reporting Person: Nielsen Jack (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-14 | Stock Option (Right to Buy) | $11.18 | A | 1500 | Acquired | 2033-06-13 | Common Stock (1500) | Direct |
Footnotes
F1: The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date.
More from Instil Bio, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Jan 6
Interim / Quarterly Report
2025
Nov 13